BrainImmunex's aBAM technology is our proprietary innovation addressing and enhancing the limitations associated with existing neurodegenerative diseases. By controlling the fundamental risk factor of brain aging, our technology aims to bring hope for a cure to patients and their families who are still grappling with these conditions.